Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions

BMC Medicine
Andrea L CiaranelloValeriane Leroy


Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-child transmission (PMTCT) services, but has been challenging to implement in resource-limited settings. In order to correctly inform parents/caregivers of infant infection status and link HIV-infected infants to care and treatment, a 'cascade' of events must successfully occur. A frequently cited barrier to expansion of EID programs is the cost of the required laboratory assays. However, substantial implementation barriers, as well as personnel and infrastructure requirements, exist at each step in the cascade. In this update, we review challenges to uptake at each step in the EID cascade, highlighting that even with the highest reported levels of uptake, nearly half of HIV-infected infants may not complete the cascade successfully. We next synthesize the available literature about the costs and cost effectiveness of EID programs; identify areas for future research; and place these findings within the context of the benefits and challenges to EID implementation in resource-limited settings.


May 1, 1995·The Pediatric Infectious Disease Journal·C J ChantryC Diaz
Aug 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M WilfertR J Simonds
May 1, 1996·JAMA : the Journal of the American Medical Association·D K OwensS Sonnad
Mar 4, 2000·Pediatric Clinics of North America·K Nielsen, Y J Bryson
Oct 18, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·N L YoungUNKNOWN Bangkok Collaborative Perinatal HIV Transmission Study Group
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joseph M MrusJoel Tsevat
Dec 6, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·John S LambertLynne M Mofenson
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Albert FayeUNKNOWN French Perinatal Study Group
Mar 29, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Courtney C Maclean, Jeffrey S A Stringer
Sep 9, 2005·The Pediatric Infectious Disease Journal·Ellen Gould ChadwickUNKNOWN PACTG Protocol 345 Team
Nov 3, 2005·Tropical Medicine & International Health : TM & IH·Gayle G ShermanStephanie A Jones
Mar 3, 2006·AIDS·Elena ChiappiniUNKNOWN Italian Register for HIV Infection in Children
Dec 6, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Marlyse C KnuchelJörg Schüpbach
Dec 7, 2006·Cost Effectiveness and Resource Allocation : C/E·Susan M ClearyAndrew M Boulle
Dec 13, 2006·Nature·Karen A RicciRichard L Guerrant
May 4, 2007·Journal of Clinical Microbiology·Susan A FiscusRichard A Respess
Sep 14, 2007·American Journal of Obstetrics and Gynecology·Tracy L CreekNathan Shaffer
Nov 14, 2007·International Journal of Epidemiology·Elise ArrivéUNKNOWN KIDS-ART-LINC Collaboration
Dec 7, 2007·Pediatrics·Jennifer S Read, UNKNOWN Committee on Pediatric AIDS, American Academy of Pediatrics
Jun 6, 2008·The New England Journal of Medicine·Louise KuhnUNKNOWN Zambia Exclusive Breastfeeding Study
Nov 21, 2008·The New England Journal of Medicine·Avy ViolariUNKNOWN CHER Study Team
Dec 6, 2008·Tropical Medicine & International Health : TM & IH·Peter IliffJean Humphrey

❮ Previous
Next ❯


Jan 25, 2014·The Lancet Infectious Diseases·Martina PenazzatoDiana M Gibb
Jun 27, 2012·Lab on a Chip·Brittany A Rohrman, Rebecca R Richards-Kortum
Nov 30, 2012·Journal of Public Health Policy·Agnes BinagwahoMary C Smith Fawzi
Jun 9, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Silvia BertagnolioUNKNOWN Pediatric HIV ResNet Working Group
Sep 1, 2012·The Pediatric Infectious Disease Journal·Benjamin H ChiJeffrey S A Stringer
Sep 6, 2012·AIDS·Celina WettsteinUNKNOWN IeDEA Southern Africa Collaboration
Oct 4, 2013·BMC Public Health·Mercy G ChiduoTerese L Katzenstein
Dec 19, 2013·PloS One·Andrea L CiaranelloKenneth A Freedberg
Feb 9, 2012·The Indian Journal of Medical Research·S N MothiS M Sarvode
Apr 26, 2014·Journal of the International AIDS Society·Fatoumata DickoUNKNOWN Pediatric IeDEA West Africa Working Group
Sep 2, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·M BouraimaD K Ekouevi
Jan 29, 2016·Journal of Virological Methods·Lorraine LillisDavid S Boyle
Dec 27, 2015·Journal of Virological Methods·Sokhna Bousso GueyeCoumba Touré-Kane
Dec 25, 2015·Healthcare : the Journal of Delivery Science and Innovation·S Finocchario-KesslerK Goggin
Mar 13, 2016·Journal of the International AIDS Society·Thananda NaiwatanakulSorakij Bhakeecheep
Mar 25, 2014·Paediatrics and International Child Health·Sara-Jane SmithPravi Moodley
Sep 8, 2015·Journal of the International AIDS Society·Lorna DunningLandon Myer
Jul 15, 2015·Implementation Science : IS·Sarah Finocchario-KesslerVincent Okoth
Feb 2, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jeanne A JordanGary L Simon
Jan 24, 2015·Archives of Disease in Childhood·Andrew J PrendergastMartina Penazzato
Jan 4, 2013·Bulletin of the World Health Organization·Grace Wu, Muhammad H Zaman
Jun 1, 2016·The Lancet. HIV·Wasna SirirungsiTanawan Samleerat
Nov 2, 2014·PloS One·Malik CoulibalyUNKNOWN MONOD Study Group ANRS 12206

❮ Previous
Next ❯

Methods Mentioned


Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.